Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additive short-contact coal tar derivatives with UVB therapy in plaque psoriasis
2009-010863-18Phase 4Active
- Sponsor
- Amphia Ziekenhuis
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of coal tar solution in plaque psoriasis (2 arms), sponsored by Amphia Ziekenhuis. Primary endpoints: Number of UVB sessions until clearance, Cumulative UVB dose until clearance and 1 more. Started Mar 2009; status: active.
02
Drugs
coal tar solution
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2009-010863-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010863-18.